Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Use formulas for budget calculations to automate totals, forecast outcomes, and reveal spending patterns with confidence.
10,965 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
CoreWeave stock gets headlines can spark investor interest, but smart portfolios look beyond headlines. This guide ex...
Fame can be fleeting. These nine actors died just they were about to break out, leaving behind not only memories but ...
An explosion at a Texas refinery sparked a large smoke plume and led to shelter-in-place orders for nearby communitie...
A new class of job-search firms charges up front fees to run an entire hunt for candidates. The market that reverse r...
The White House rejected Elon Musk’s public offer to fund TSA salaries during the budget stalemate, setting off a fre...
The market mood says AI spending is peaking. But one company’s long-term orders hint at a different story. This guide...
Carvana’s eye-popping ascent sparked debates about online car shopping and disruption. As Amazon weighs in on automot...
Federal regulators capped Eversource’s base ROE, creating a near-term earnings hurdle even as the utility doubles dow...
The latest data show the U.S. public debt now tops the nation's GDP, a milestone with potential implications for rate...
A wave of weaker confidence is reshaping housing activity, even as the job market holds steady. This guide breaks dow...
Artificial intelligence is reshaping how companies operate and compete. This guide highlights two standout AI stocks ...